Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound

BACKGROUND: Therapy for glioblastoma (GBM) has always been very challenging, not only because of the presence of the blood-brain barrier (BBB) but also due to susceptibility to drug resistance. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (CRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiang, Zhou, Yanghao, Chen, Jin, Huang, Ning, Wang, Zhigang, Cheng, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802796/
https://www.ncbi.nlm.nih.gov/pubmed/33447034
http://dx.doi.org/10.2147/IJN.S286221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802796/
https://www.ncbi.nlm.nih.gov/pubmed/33447034
http://dx.doi.org/10.2147/IJN.S286221

Ejemplares similares